114  Total SME IPOs listed in 2025

5,174.44 Crs.  Total funds raised in 2025

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

114  Total SME IPOs listed in 2025

5,174.44 Crs.  Total funds raised in 2025

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

114  Total SME IPOs listed in 2025

5,174.44 Crs.  Total funds raised in 2025

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

114  Total SME IPOs listed in 2025

5174.44 Crs.  Total funds raised in 2,025.00

79  SME IPOs listed with Gain in 2025

35  SME IPOs listed with loss in 2025

Syngene International IPO (Syngene International Limited IPO) Detail

Syngene International IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 550.00 Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Axis Bank , Credit Suisse Securities (India) , Jefferies India are the merchant bankers of Syngene International IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st July 2015.

Syngene International IPO open date is 27th July 2015 and close date is 29th July 2015. IPO Allotment Date is 30th November -0001 and Listing date is 11th August 2015.

IPO Category : MainBoard
Exchange : BSE,NSE
Issue Type : Book Building

IPO Key Highlights

Syngene International IPO Date

Date of DRHP:
31st July 2015
IPO Open Date:
27th July 2015
IPO Close Date:
29th July 2015
IPO Allotment Date:
[●]
Initiation of Refund:
[●]
IPO Listing Date:
11th August 2015

Syngene International IPO Info, Size, Subscription

Syngene International IPO size is ₹ 550.00 Cr. with IPO price of ₹ 250.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.

IPO Size :
₹ 550.00 Cr.

Issue Price:
₹ 250.00

Market Capitalisation :
₹ 0.00 Cr.

PE multiple :
27.00

Subscription :
32.05 times

Pre Issue Promoter Holding :
88.50 %

Post Issue Promoter Holding :
74.50 %

Syngene International IPO Information

Sub Sector : development and manufacturing at its ultra modern world class research and development facility
Syngene International Limited is one of the leading India-based contract research organizations (CRO), offering a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across various industrial sectors, including pharmaceuticals, biotechnology, agrochemicals, consumer health, animal health, cosmetics, and nutrition companies. Its service offerings in discovery and development span multiple domains, including small molecules, large molecules, antibody-drug conjugates (ADC), and oligonucleotides.

The company's integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluations, formulation development, and stability studies), and pilot manufacturing (scale-up, pre-clinical, and clinical supplies) under one roof, providing a distinctive economic advantage. The company's services also support the development of biosimilar and generic molecules. In
Show More

Object of Issue (Syngene International IPO Objectives)

  • Achieve the benefits of listing the Equity Shares on the Stock Exchanges
  • Enhance visibility and brand image among existing and potential clients and
  • Provide liquidity to the existing shareholders

Axis Bank Limited is the book-running lead manager of the Syngene International IPO. Kfin Technologies Limited is the Registrar for Syngene International IPO.

Syngene International IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.

What is Syngene International IPO?

Syngene International IPO, based in Bangalore, operates in the   Pharmaceutical sector with a focus on development and manufacturing at its ultra modern world class research and development facility. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Syngene International IPO size is ₹ 550.00 Cr. with fresh issue size of ₹ 550 and Offer for sale being ₹ Nil

When is Syngene International IPO allotment?

The IPO allotment date for Syngene International IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Syngene International IPO allotment status on the registrars website, Kfin Technologies Limited . Syngene International IPO refund dates are 30th November -0001.

When is Syngene International IPO listing date?

Syngene International IPO is expected to be listed on 11th August 2015.

What is the price band for Syngene International IPO?

The upper price band for the Syngene International IPO is set at ₹ 250.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.

What is Syngene International IPO Review?

For IPO analysis on Syngene International IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.

How to Apply for Syngene International IPO?

To apply for the Syngene International IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 29th July 2015. After submission, funds are blocked until the basis of allotment of Syngene International IPO is finalised.

Who is the merchant banker of Syngene International IPO?

The merchant banker for Syngene International IPO is Axis Bank Limited , Credit Suisse Securities (India) Private Limited , Jefferies India Private Limited . Axis Bank Limited , Credit Suisse Securities (India) Private Limited , Jefferies India Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Syngene International IPO RHP for further details.

Who is the Registrar of Syngene International IPO?

The registrar for Syngene International IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Syngene International IPO through their official website or helpline.

What is the Syngene International IPO subscription?

Syngene International IPO was subscribed 32.05 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.

IPO Key Highlights

Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Recent IPO List

Anthem Biosciences Limited

  Pharmaceutical

  Bangalore


Smartworks Coworking Spaces Limited

  Corporate Solutions

  New Delhi


Travel Food Services Limited

  Hotels and Resorts - QSR

  Mumbai


Crizac Limited

  Education - Edtech

  Kolkata


Indogulf Cropsciences Limited

  Agro

  New Delhi


Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Recent IPO List

Anthem Biosciences Limited

  Pharmaceutical

  Bangalore


Smartworks Coworking Spaces Limited

  Corporate Solutions

  New Delhi


Travel Food Services Limited

  Hotels and Resorts - QSR

  Mumbai


Crizac Limited

  Education - Edtech

  Kolkata


Indogulf Cropsciences Limited

  Agro

  New Delhi


Read more details of this IPO

Peer Companies Of This Sector

FAQs

Syngene International IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Syngene International Financial Review Page

Syngene International IPO subscription was 32.05 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Syngene International IPO listed at a listing price of 310.40 against the offer price of 250.00.

The current market price of Syngene International is 657.25.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency